Bio-Key Intl Inc Stock Price, News & Analysis

BIO-key International (NASDAQ: BKYI) has secured over $600K in follow-on orders from a prominent defense ministry's cyber-defense unit for its biometric authentication solution. The orders include biometric hardware and authentication software for Q2 2025 delivery. The ministry has implemented BIO-key's solution across new programs, serving 47,000 users with 40,000 fingerprint scanners. The platform integrates with the ministry's authentication federation system, providing secure biometric access across organizational boundaries. The solution has proven more reliable and cost-effective than hardware security keys, with credentials that cannot be shared, delegated, phished, or forgotten. BIO-key anticipates future orders as the ministry expands its implementation.

BIO-key International (NASDAQ: BKYI) has announced a strategic partnership with Runlevel, a cybersecurity solutions provider, to expand its Identity and Access Management (IAM) solutions in Portuguese-speaking African countries (PALOP) and Timor-Leste. The partnership has already secured its first major customer - a National Bank in Mozambique, which will implement BIO-key's biometric-based IAM solutions including PortalGuard On-Prem with Multi-factor Authentication and Single Sign-On capabilities.

As part of BIO-key's Channel Alliance Partner program, Runlevel will serve as a Value-Added Reseller, providing pre-sales consulting, deployment support, and technical training tailored to local regulatory requirements. This partnership marks BIO-key's strategic expansion into Portuguese-speaking markets and strengthens its position in the global financial sector.

BIO-key International (Nasdaq: BKYI), a provider of Identity and Access Management (IAM) solutions featuring Identity-Bound Biometric (IBB) authentication, has announced its participation in two upcoming investor presentations. The company will present at the Aegis Capital Virtual Conference on Thursday, May 22, 2025, from 11:30 to 11:55 a.m. ET, and participate in a fireside chat at the Maxim Virtual Tech Conference on Wednesday, June 4, 2025, at 11:00 a.m. ET. The Maxim conference will be hosted on M-Vest, requiring membership registration for access. Investors can submit questions and request management meetings through both events.

BIO-key International (NASDAQ: BKYI) has announced a strategic partnership with Cloud Distribution Co., a Value-Added Distributor based in Saudi Arabia, to expand its Identity and Access Management (IAM) and biometric authentication solutions across the Middle East. Cloud Distribution joins BIO-key's Channel Alliance Partner program and will distribute BIO-key's complete suite of solutions in Saudi Arabia, UAE, and the region.

Cloud Distribution has invested in dedicated resources in Riyadh, including a Pre-Sales Engineer, Business Development Manager, and Project Manager, specifically for BIO-key operations. The partnership will focus on key technologies including PortalGuard IAM platform, Passkey:YOU, PIN:You, WEB-key biometric engine, Identity-Bound Biometrics, and certified biometric scanners.

BIO-key International (NASDAQ: BKYI) reported Q1 2025 financial results with revenue of $1.6M, down 25% year-over-year but up 10% sequentially. The revenue decline was primarily due to a comparison with a $1.2M two-year contract in Q1'24 versus $690k in Q1'25 from the same customer. The company maintained a strong gross margin of 83% and improved its cash position to $3.1M. Notable achievements include new partnerships in Spain and Portugal, deployments for defense agencies, and expansion in the education sector. Operating expenses decreased by 23% year-over-year, though net loss increased to $736,545 ($0.16 per share) compared to $510,285 ($0.32 per share) in Q1'24. The company is transitioning to selling high-margin BIO-key branded products in EMEA markets and expects significant revenue growth from its financial services customer in 2026.

BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions featuring Identity-Bound Biometric capabilities, has scheduled its first quarter 2025 earnings conference call for Friday, May 16th at 10:00 AM ET. The company will release its Q1 2025 financial results after market close on Thursday. The conference call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, followed by a Q&A session.

Investors can access the call via phone at 1-877-418-5460 (U.S.) or 1-412-717-9594 (International). A webcast replay will be available for 3 months, and an audio replay can be accessed using code 6501265.

BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management solutions, has successfully regained compliance with Nasdaq listing requirements. The company had received a non-compliance notice on April 17, 2025, due to failing to timely file its Annual Report (Form 10-K) for the year ended December 31, 2024, violating Nasdaq Listing Rule 5250(c)(1).

The notification did not immediately affect BKYI's listing status on the Nasdaq Capital Market. The company resolved the issue by filing its Form 10-K on April 23, 2025, and received confirmation of compliance restoration from Nasdaq on April 24, 2025, officially closing the matter.

BIO-key International (NASDAQ: BKYI) has announced a strategic partnership with Arrow ECS Iberia, a leading cybersecurity distributor in Spain and Portugal. The partnership, which adds Arrow ECS Iberia to BIO-key's Channel Alliance Partner program, aims to expand the availability of BIO-key's Identity and Access Management (IAM) solutions across the Iberian market.

The partnership will be officially unveiled at the Arrow ECS Event on April 2, 2025, at MEO ARENA in Lisbon, where over 800 partners and cybersecurity experts are expected to attend. BIO-key will showcase their solutions including Multi-factor Authentication (MFA), Single Sign-On (SSO), and Identity-Bound Biometrics (IBB).

Arrow ECS Iberia will provide pre-sales consultation, technical training, and deployment support for BIO-key's solutions, focusing on regulatory compliance with NIS2 and GDPR directives. The partnership targets key industries including financial services, healthcare, critical infrastructure, and the public sector.

BIO-key International (Nasdaq: BKYI) reported its Q4 and full-year 2024 results, showing significant financial improvements despite an 11% revenue decline to $6.9M. The company's strategic shift away from Swivel Secure products to focus on high-margin software solutions led to a 20% increase in software license revenue to $5.2M.

Key financial highlights include:

• Net loss reduced by 49% to $4.3M in 2024
• Gross profit grew to $5.6M in 2024 from $1.4M in 2023
• Operating expenses reduced by 6% to $9.7M
• Cash used in operations decreased 23% to $2.91M

Notable achievements include partnerships with California Ed Tech JPA (reaching 195 institutions), National Bank of Egypt deployment, and securing a $910K financial services contract and $500K in defense ministry orders. The company's focus on passwordless, phoneless, and tokenless authentication solutions shows growing market traction, particularly in EMEA regions.